Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease

Abstract

Our long term cohort supports the current evidence on the effectiveness and safety of anti-TNFα treatment in children with IBD. Response to treatment was interestingly associated with lower weight and BMI.